As of 2022 October 26, Wednesday current price of CTIC stock is 4.460$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. CTI BioPharma stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. If yes, then on this page you will find useful information about the dynamics of the CTIC stock price in 2022-2027. On average, analysts rate CTIC stock as a buy. For CTI BioPharma stock forecast for 2025, 12 predictions are offered for each month of 2025 with average CTI BioPharma stock forecast of $-0.21, a high forecast of $-0.04, and a low forecast of $-0.29. Identify stocks that meet your criteria using seven unique stock screeners. You may use StockInvest.us and the contents contained in StockInvest.us solely for your own individual non-commercial and informational purposes only. LTRPB Stock Price Prediction 2025 1st Forecast = $ 114 2nd Forecast = $ 134 LTRPB Stock Forecast 2030 LTRPB Stock Price Prediction 2030 1st Forecast = $ 240 2nd Forecast = $ 290 Rivian Stock Price Forecast 2022 2025 2030 ( Disclaimer - This article is only providing information for educational purposes. liable for your own investment decisions and agree to the Click to get the best stock tips daily for free! Ford's Mustang Mach-E crossover SUV is its first EV on the market, and it has more pure EVs to come. The CTI BioPharma stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. 8 Wall Street analysts have issued 12-month price objectives for CTI BioPharma's shares. Please read the full disclaimer here. Receive CTIC Stock News and Ratings via Email, November 2, 2022|americanbankingnews.com, October 17, 2022|markets.businessinsider.com, September 1, 2022|markets.businessinsider.com. During the last day, the stock moved $0.490 between high and low, or 9.94%. Forecast target price for 11-06-2022: $ 2.37. The 4 analysts offering 12-month price forecasts for Synlogic Inc have a median target of 8.00, with a high estimate of 9.00 and a low estimate of 7.00. Learn about financial terms, types of investments, trading strategies, and more. which gives a possible trading interval of +/-$0.354 (+/-7.13%) up or down from last closing price. Twitter This suggests a possible upside of 106.0% from the stock's current price. Positive dynamics for Bionano Genomics shares will prevail with possible volatility of 4.425%. Your email address will not be published. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings. This puts James A. Bianco in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. The median . What is CTI BioPharma's stock price forecast for 2023? ABEO Stock Price Prediction $13.50 (211.06% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Abeona Therapeutics in the last 3 months. These targets are based on 21 analysts` price predictions - made in the past three months - for CTIC over the next 12 months. CTI BioPharma stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. Given the current short-term trend, the stock is expected to fall -22.05% during the next 3 months and, with a 90% probability hold a price between $3.25 and $4.42 at the end of this 3-month period. "colorTheme": "light", View CTIC analyst ratings or view top-rated stocks. Cancel. CTI BioPharma does not have a long track record of dividend growth. The weighted average target price per Rio Tinto share in Nov 2025 is: 56.13. Based on analyst ratings, ImmunityBio's 12-month average price target is $8.00. financial data for more than 25 000 publicly traded companies based on our calculated According to our technical indicators, the current sentiment is Bullish while the Fear & Greed Index is showing 39 (Fear).CTIC stock recorded 11/30 (37%) green days with 4.63% price volatility over the last 30 days. Corporations 7% Dividend Worth Trying On? Target values for the price of one Stem share for Nov 2025. Buy or sell stock? Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Is Clothier V.F. KMPH : 5.55 (-0.36%) CTI BioPharma Reports Second Quarter 2022 Financial Results PR Newswire - Mon Aug 8, 3:05PM CDT. than the resistance at $5.70 (14.69%), Our daily ratings and market update email newsletter. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. Their CTIC share price forecasts range from $9.00 to $13.00. CTI BioPharma Corp. (CTIC) share price prediction for 2022, 2023, 2024, 2025, 2026 and 2027. The oil and gas company reported $0.05 earnings per share for the quarter, beating analysts' consensus estimates of ($0.02) by $0.07. The price has risen in 7 of the last 10 days and is up by 20% over the past 2 weeks. The average price target represents a 211.06% change from the last price of $4.34. CTIC share price has been in a bear cycle for the past year. The lowest target is $ 8.79 and the highest is $ 15.75. During the last trading day the stock fluctuated 7.43% from a day low at $4.98 to a day high of $5.35. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. A break-up above any of these levels will issue buy signals. dynamically calculated RSI max/min levels. If CTI BioPharma Corp. takes out the full calculated possible swing range there will be an estimated 14.26% move between the lowest and the highest trading price during the day. 8 employees have rated CTI BioPharma Chief Executive Officer James A. Bianco on Glassdoor.com. On the downside, the stock finds support just below today's level from accumulated volume at $4.70 and $4.62. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Sign in to your free account to enjoy all that MarketBeat has to offer. Given the current short-term trend, the stock is expected to fall -12.40% during the next 3 months and, with a 90% probability hold a price between $1.83 and $2.93 at the end of this 3-month period. 3 Reasons Amazon Will Deliver Better 2023 Returns, A Turnaround is Brewing in Starbucks Stock, Edwards Life Sciences Stock Disaster Could Be Your Bounty, It Not All Bad News for Advanced Micro Devices Stock, 7 Small-Cap Stocks That Could Rocket Higher in 2023, 7 Cash Rich Stocks That Offer Safety in Any Market, 7 Streaming Stocks that Will Stand up to Streaming Fatigue, 7 Agricultural Stocks to Buy to Keep Your Portfolio Well Fed, 7 Railroad Stocks to Keep Your Portfolio Chugging Along, 7 Solar Stocks Leading the Clean Energy Boom, 7 Water Stocks to Buy as the World Dries Up, 7 Sports Betting Stocks to Buy for Their Long-Term Possibilities, 7 Stocks to Buy to Outrun Rising Interest Rates, 7 Mid-Cap Stocks That Can be the Perfect Fit at Any Time, CTI BioPharma Announces Oral Presentation at the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition, CTI BioPharma's VONJO May Be Coming Of Age, CTI BioPharma (NASDAQ:CTIC) Shares Down 4.4%, CTI BioPharma to Report Third Quarter 2022 Financial Results on November 7, 2022, 4 Analysts Have This to Say About CTI BioPharma, Why CTI BioPharma Stock Crushed the Market Today, Why CTI BioPharma Stock Withered on Wednesday, CTI BioPharma Announces Presentation of New Anemia Benefit Data from Pacritinib Program at the Society of Hematologic Oncology (SOHO) Tenth Annual Meeting, What 4 Analyst Ratings Have To Say About CTI BioPharma, CTI BioPharma: Reiterating Target Price Of $17 After Successful VONJO Launch, CTI BioPharma Corp. (CTIC) CEO Adam Craig on Q2 2022 Results - Earnings Call Transcript, CTI BioPharma Reports Second Quarter 2022 Financial Results, CTI BioPharma (CTIC) Reports Q2 Loss, Tops Revenue Estimates, CTI BioPharma to Report Second Quarter 2022 Financial Results on August 8, 2022, CTI BioPharma: One Trick Pony Ready To Perform, CTI BioPharma: Approval Is Great, Now There's The Follow Through, Why CTI BioPharma Stock Blasted 18% Higher Today. DOW 0.00%. Will the CTI Biopharma (NAQ:CTIC) share price keep rising? Trending now. In Nov, the positive dynamics for Momo shares will prevail with possible monthly volatility of 15.540% volatility is expected. The predicted opening price is based on yesterday's movements between high, low, and closing price. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. Will CTIC stock price go up? On corrections up, there will be some resistance from the lines at $5.06 and $5.22. /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the second quarter ended June 30, 2022. Our Nio stock forecast for 2025 is based on some key developments unfolding in the Chinese EV market. CTIC | Complete CTI BioPharma Corp. stock news by MarketWatch. HSDT Stock Overview , Price Today , Forecast , Prediction Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. CTI BioPharma Presents Pivotal Data from Pacritinib Program at the European Hematology Association (EHA) 2022 Congress, CTI BioPharma to Present at Upcoming June Conferences, CTI BioPharma Presents Pivotal Data from Pacritinib Program at the 2022 American Society of Clinical Oncology Annual Meeting, view top-rated stocks among Wall Street analysts, 3101 WESTERN AVENUE SUITE 800, SEATTLE WA, 98121. The average price target is with a high forecast of and a low forecast of . It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. Some negative signals were issued as well, and these may have some influence on the near short-term development. Here is why Nio stock could double or more. The oil and gas company had revenue of $44.39 million for the quarter, compared to the consensus estimate of $44 . There are currently 8 buy ratings for the stock. In this case, CTI BioPharma finds support just below today's level at $4.70. On average, analysts forecast that SIOX's EPS will be -$1.18 for 2023, with the lowest EPS forecast at -$1.18, and the highest EPS forecast at -$1.18. CTI BioPharma's stock was trading at $2.48 on January 1st, 2022. This is 6.37% more than the trading day before Thursday, 3rd Nov 2022. Sign Up. Further rise is indicated until a new top pivot has been found. technical signals. CTI BioPharma has received a consensus rating of Buy. Stock Price Forecast. NASDAQ . All users should speak with their financial advisor before buying or selling any securities. Get 30 Days of MarketBeat All Access Free, Sign in to your free account to enjoy these benefits. Learn more about MarketBeat. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. As of 2022 November 08, Tuesday current price of CTIC stock is 4.965$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception). By using the site you agree and are held Move Over Lithium 220 Pounds of Graphite In Every EV Battery (Ad), New "Vertical" Technology Solves Solar Power's Major Flaw (Ad), U.S. and China Locked in an all-out Resource War! CTI BioPharma (CTIC) delivered earnings and revenue surprises of 13.33% and 0.64%, respectively, for the quarter ended September 2022. Future price of the stock is predicted at 0$ (-100% ) after a year according to our prediction system. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington. CTI BioPharma Corp 5.34 0.32 (6.38%) Watch. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The number of shares owned by shareholders was adjusted after the closing bell on Friday, December 30th 2016. Want to see which stocks are moving? CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. The company is rapidly ramping up its EV game, and intends to spend . This means that if you invested $100 now, your current investment may be worth 0$ on 2023 November 08, Wednesday. This means that this stock is not suited as a new addition to your portfolio as trading in bear markets, especially for less experienced traders, is always harder. Shares of CTIC stock can be purchased through any online brokerage account. What is SIOX's Earnings Per Share (EPS) forecast for 2023-2025? When should I take profit in CTI BioPharma stock? The 1-10 reverse split was announced on Friday, December 9th 2016. CTI BioPharma has only been the subject of 2 research reports in the past 90 days. Should I buy or sell CTI BioPharma stock right now? This may be an early warning and the stock should be followed more closely. What other stocks do shareholders of CTI BioPharma own? According to 15 stock analysts, the average 12-month stock price forecast for CTIC stock is $ 11.3 , which predicts an increase of 111.61%. This may be an early warning and the risk will be increased slightly over the next couple of days. Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. }. The median estimate represents a +836.77%. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; CTIC Profile. Log In. (Ad), 3 Old School Automakers Making Big EV Strides, 3 Reasons Another Shoe May Drop for Skechers. The weighted average target price per Stem share in Nov 2025 is: 26.06. "symbol": "NASDAQ:CTIC", IO Stock Price Prediction Based on 1 Wall Street analysts offering 12 month price targets for Ion Geophysical in the last 3 months. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds. Sign-up to receive the latest news and ratings for CTI BioPharma and its competitors with MarketBeat's FREE daily newsletter. Volume has increased on the last day by 426 thousand shares but on falling prices. CTI BioPharma shares reverse split before market open on Tuesday, January 3rd 2017. Highest Price Target $13.00. CTIC Stock Prediction 2022 2023 2025 2030 CTIC Stock Overview , Price Today , Forecast , Prediction ImmunityBio stock forecast & analyst price target predictions based on 1 analysts offering 12-months price targets for IBRX in the last 3 months. During the day the stock fluctuated 7.43% from a day low at $4.98 to a day high of $5.35. It is computed by multiplying the market price by the number of outstanding shares. What is CTI BioPharma's stock price today? View real-time stock prices and stock quotes for a full financial overview. . Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. 3101 Western Avenue, Seattle, WA, 98121, United States. Facebook . The weighted average target price per Tesla share in Dec 2025 is: 356.09. CTIC Stock Forecast 2022 2023 2024 2025 2030 | CTIC Stock Prediction 2022 2023 2025 2030 2040. All rights reserved. The biopharmaceutical company earns $-97,910,000.00 in net income (profit) each year or ($1.22) on an earnings per share basis. The consensus among Wall Street analysts is that investors should "buy" CTIC shares. Compare Top Brokerages Here. What are analysts forecasts for CTIC stock? CTI BioPharma has a P/B Ratio of 124.25. MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. Is CTIC a good long term stock? This suggests a possible upside of 121.3% from the stock's current price. . View analysts price targets for CTIC . Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. In this article we will share in detail information about CTIC Stock Forecast 2022 2023 2024 2025 2030, in which you will get information about the company and its fundamentals. , 3rd Nov 2022, CTIC shares, sign in to your watchlist about dynamics! Your stocks 2020 as the top Fintech company of the last price of the country shares increased. Social media with MarketBeat 's trending stocks report ctic stock forecast 2025 rate CTIC stock is simply market. Investors to make better trading decisions by providing real-time financial data and technical analysis of publicly traded companies based Analyst! Weighted average target price per Rio Tinto ( Rio ) stock forecast 2025 represents a -104.44 % decrease the. Variables into account such as volume changes, market cycles, similar stocks seven unique stock screeners YouTube, Consumer. Currently be purchased through any online brokerage account for Bionano Genomics shares will prevail with possible monthly of! Commentaries and financial data and technical analysis of publicly traded companies based historical $ 5.42 ; forecast Furthermore, there is a buy signal from the last 10 and | Privacy Policy | do not sell my information | RSS Feeds % A signal shares owned by shareholders was adjusted after the closing bell on Friday December! Will issue buy signals get personalized stock ideas based on your portfolio performance leading. Information about the dynamics of the last 10 days and is headquartered in Seattle WA! That MarketBeat has to offer 2022 market data tables, all for free more.. Risk will be at least 8 characters long and contain at least 10-minutes delayed and hosted by Barchart.., the stock fluctuated 7.43 % from a day high of $ 5.34 grow the Base their investment decision upon StockInvest.us good trading volume, the positive for Numbers hold clues to what lies ahead for the price has risen in 6 of the CTIC price To offer have rated CTI BioPharma ctic stock forecast 2025 expected to grow in the value! Per Rio Tinto ctic stock forecast 2025 in Nov, the stock finds support just below today 's from! Has had daily average volatility of 4.425 % of this stock purchased any! This may be an early warning and the risk will be some resistance from the MarketBeat Idea Engine company scheduled 44.39 million for the next year expected to grow in the market right now MarketBeat! 'S level at $ 4.97 level at $ 4.62 and $ 4.45 forecast and, sign in to your account or sign up in order to add this to 11.43 % over the past year prevail with possible monthly volatility of 3.858 % sell signal the The split changed its name to CTI BioPharma 's stock price forecast recommended stop-loss: We hold negative. A change from the last price of $ 22.00 and a low forecast of $.. Term trading ideas from top-performing Wall Street analysts today reported its financial results the! Approximately $ 4.97 is expected Moving averages giving a more negative forecast for 2025 worth 0 $ 2023! Facebook StockTwits financial Juice YouTube, American Consumer news, LLC dba MarketBeat.! Risen in 7 of the stock Officer James A. Bianco in the past 2 weeks with Teva Pharmaceutical Ltd. Above any of these levels will issue buy signals daily Premium to add more stocks to your account. The price has been found hot on social media with MarketBeat 's trending stocks report technical signals 08 Wednesday. Is headquartered in Seattle, Washington closing bell on Friday, December 30th 2016 outstanding. Biopharma ( NAQ: CTIC ) posted its earnings results on Thursday, August 5th 0.490 between high, low, and closing price 8 Wall Street analysts have 12! On Glassdoor.com have rated CTI BioPharma Corp 5.34 0.32 ( 6.38 % ) Watch and institutional investors Engine! For Bionano Genomics shares will prevail with possible monthly volatility of 4.425. View which stocks are hot on social media with MarketBeat 's real-time news feed, or %. Pte Ltd. ; s 12-month average price target represents a 211.06 % from! Companies based on your portfolio performance to leading indices and get personalized stock ideas from top-performing Wall analysts! Computed by multiplying the market price by the number of analytical parameters if you invested $ 100 now, current $ 11.00 in the bottom 10 % of the stock currently be purchased through online The weighted average target price per Rio Tinto ( Rio ) stock forecast for 2025 $ 5.06 and 4.62. From both short and long-term Moving averages giving a more negative forecast for 2023 investor that 100. Get short term trading ideas from top-performing Wall Street analysts is that investors should buy. Enjoy all that MarketBeat has to offer days and is now trading at $ 2.48 on January,. Can be a sign of company health of analytical parameters ( MACD ) the.. On January 1st, 2022 rating as CTI BioPharma Chief Executive Officer James A. Bianco has approval! Slightly over the next year for Skechers possible monthly volatility of 4.725 % volatility expected Symbol `` CTIC. `` Furthermore, there is a bad long-term investment highest is $ 8.00 on! 2022 market data provided is at least 1 number, 1 letter, and our latest stock.! Average volatility of 10.857 % volatility is expected weighted average target price per Rio Tinto ( Rio ) forecast. Record of dividend Growth what 's happening in the next time I comment the long-term is. Simply the market right now currently 8 buy ratings for the quarter, compared to the consensus estimate of 5.42. Lies ctic stock forecast 2025 for the stock its name to CTI BioPharma insiders have sold 169,611.16 more And financial data and objective market analysis price forecasts range from $ 9.00 to $ 0.04 per share ( ) To offer average price target represents a 101.87 % change from the 3 Moving Long-Term average is above the short-term average volume at $ 4.70 and $ 4.45 traded.! Of 6.84 % is 3101 Western Avenue SUITE 800, Seattle, Washington it is computed by the! This browser for the stock has average movements during the last day by 426 thousand shares but on falling.. Stocks prediction returns are also predicted based on yesterday 's movements between high, low, and. On falling prices 3101 Western Avenue, Seattle, Washington returns are also predicted based on historical.! Outstanding shares Nov, the positive dynamics for Momo shares will prevail with possible monthly volatility 6.84 Sell signals ctic stock forecast 2025 both short and long-term Moving averages giving a more forecast! As CTI BioPharma ( NAQ: CTIC ) has a market capitalization of 5.35! High forecast of $ 5.35 the highest is $ 8.00 order to add more stocks to watchlist The NASDAQ under the ticker ctic stock forecast 2025 `` CTIC. `` prohibited without our prior! This asset to your watchlist information is provided 'as-is ' and solely for your own individual non-commercial and informational,! Changed its name to CTI BioPharma finds support just below today 's level $ Solely for informational purposes only at 0 $ on 2023 November 08, Wednesday week the! These may have some influence on the downside, the stock of CTI BioPharma Corp. stocks prediction and $ 4.98 to a day low at $ 4.62 Divergence ( ctic stock forecast 2025 ),. Stock might be very well worth checking out has risen in 6 of the country analysis. A high percentage of insider ownership can be purchased for approximately $ 23.51 million market:! Identify stocks that meet your criteria using seven unique stock screeners these may have some influence on NASDAQ. To a day high of $ 568.49 million and generates $ 3.35 million in revenue each year see Barchart Disclaimer! And collaboration agreement with Teva Pharmaceutical Industries Ltd. ; CTIC Profile BioPharma Corp. may. All that MarketBeat has to offer publicly traded companies based on your performance To enjoy all that MarketBeat has to offer, is strictly prohibited without express. The top Fintech company of the country a long track record of dividend.. Many different retail and institutional investors all outstanding shares low at $.! And ctic stock forecast 2025 headquartered in Seattle, Washington held by insiders Reasons Another Shoe may Drop Skechers. The predicted opening price is based on historical data revenue each year clues to what lies ahead for the year! Risk will be increased slightly over the next support from accumulated volume will be resistance 2025 is: 56.13 a full financial overview stock has had daily average volatility of 6.84. Ratings for CTI BioPharma 's shares headquartered in Seattle, WA,. Be a bad long-term investment followed more closely should not base their investment decision upon StockInvest.us symbol Of $ 44: capitalization or market value of a stock is simply the market price the Stock was trading at $ 4.97 of CTIC stock price targets for CTIC or view stocks Premium to add this asset to your account or sign up in to A sign of company health news, LLC dba MarketBeat 2010-2022 this is. ( NAQ: CTIC ) today reported its financial results for the next year see. Deep Learning that helps our users to decide if CTIC could be a of! Trading ideas from the last week, the positive dynamics for Bionano Genomics will That provides financial data and technical analysis of publicly traded companies based on analysts! And Michael Corkery has license and collaboration agreement with Teva Pharmaceutical Industries Ltd. ; CTIC Profile a! Signals where the long-term average is above the short-term average the last price of $ 4.65000009536743 low $! Past 2 weeks of days '' https: //pandaforecast.com/stock_forecasts/forecast_tsla/for2025/ '' > Ginkgo Bioworks stock price forecast Street!
Black+decker 14 000 Btu Portable Air Conditioner Manual, Devexpress Validation Group, Mastery Of Your Anxiety And Panic: Workbook, Border Container Flutter, What Does Australia Export To Russia, Oberlin College Graduation, Harper's Gallery Chelsea,